Unadjusted | Adjusted* | ||||||
---|---|---|---|---|---|---|---|
Outcome: long anticipated patient interval for rectal bleeding (> 1 week) | Outcome: long anticipated patient interval for rectal bleeding (> 1 week) | ||||||
Proportion with long interval (%) | OR | 95% CI | P-value | OR | 95% CI | P-value | |
Recognition of unexplained bleeding as cancer symptom | |||||||
Yes | 13.3 | Ref. | Ref. | ||||
No | 19.7 | 1.59 | 1.41–1.79 | < 0.001 | 1.90 | 1.58–2.30 | < 0.001 |
Number of negative beliefs about cancer | |||||||
0 | 13.0 | Ref. | Ref. | ||||
1 | 13.8 | 1.07 | 0.98–1.18 | 0.147 | 1.11 | 1.00–1.22 | 0.051 |
2 | 14.4 | 1.13 | 1.01–1.27 | 0.034 | 1.21 | 1.07–1.37 | 0.002 |
3 | 15.8 | 1.26 | 1.06–1.48 | 0.007 | 1.41 | 1.18–1.69 | < 0.001 |
≥ 4 | 20.3 | 1.71 | 1.34–2.18 | < 0.001 | 1.97 | 1.51–2.57 | < 0.001 |
Age group | |||||||
50–59 years | 16.6 | Ref. | Ref. | ||||
60–69 years | 14.0 | 0.82 | 0.75–0.90 | < 0.001 | 0.82 | 0.75–0.90 | < 0.001 |
70–79 years | 11.4 | 0.65 | 0.58–0.73 | < 0.001 | 0.67 | 0.59–0.76 | < 0.001 |
≥ 80 years | 8.5 | 0.46 | 0.39–0.56 | < 0.001 | 0.51 | 0.41–0.62 | < 0.001 |
Sex | |||||||
Female | 13.7 | Ref. | Ref. | ||||
Male | 14.4 | 1.06 | 0.98–1.15 | 0.152 | 1.03 | 0.95–1.12 | 0.495 |
Marital status | |||||||
Cohabiting | 14.3 | Ref. | Ref. | ||||
Single | 13.5 | 0.93 | 0.86–1.01 | 0.103 | 1.08 | 0.99–1.18 | 0.086 |
Education | |||||||
No university degree | 12.9 | Ref. | Ref. | ||||
University degree | 16.4 | 1.33 | 1.22–1.44 | < 0.001 | 1.29 | 1.18–1.41 | < 0.001 |
Smoking status | |||||||
Not current smoker | 14.0 | Ref. | Ref. | ||||
Current smoker | 13.9 | 1.00 | 0.90–1.12 | 0.990 | 0.91 | 0.81–1.02 | 0.111 |
Experience of cancer (self and/or family/friend) | |||||||
Yes | 14.2 | Ref. | Ref. | ||||
No | 12.6 | 0.87 | 0.78–0.97 | 0.010 | 0.85 | 0.76–0.95 | 0.006 |
Country | |||||||
UK | 13.6 | Ref. | Ref. | ||||
Australia | 8.6 | 0.59 | 0.52–0.68 | < 0.001 | 0.60 | 0.52–0.68 | < 0.001 |
Canada | 15.1 | 1.13 | 1.01–1.27 | 0.033 | 1.04 | 0.93–1.17 | 0.480 |
Denmark | 14.6 | 1.08 | 0.94–1.25 | 0.270 | 1.00 | 0.86–1.16 | 0.990 |
Norway | 19.4 | 1.52 | 1.34–1.74 | < 0.001 | 1.46 | 1.27–1.68 | < 0.001 |
Sweden | 17.1 | 1.31 | 1.14–1.50 | < 0.001 | 1.22 | 1.06–1.41 | 0.005 |
Test of moderation | |||||||
Negative beliefs x Non-recognition of unexplained bleeding | 0.84 | 0.75–0.95 | 0.005 | ||||
Likelihood-ratio test | |||||||
LR chi2 | 7.97 | ||||||
P-value | 0.005 |